Subgroup variations in bone mineral density response to zoledronic acid after hip fracture.
about
Zoledronic Acid (Reclast®, Aclasta®): A Review in Osteoporosis.Effects of Abaloparatide-SC on Fractures and Bone Mineral Density in Subgroups of Postmenopausal Women With Osteoporosis and Varying Baseline Risk Factors.Difference in the trajectory of change in bone geometry as measured by hip structural analysis in the narrow neck, intertrochanteric region, and femoral shaft between men and women following hip fracture.Older men who sustain a hip fracture experience greater declines in bone mineral density at the contralateral hip than non-fractured comparators.
P2860
Subgroup variations in bone mineral density response to zoledronic acid after hip fracture.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Subgroup variations in bone mi ...... ronic acid after hip fracture.
@ast
Subgroup variations in bone mi ...... ronic acid after hip fracture.
@en
type
label
Subgroup variations in bone mi ...... ronic acid after hip fracture.
@ast
Subgroup variations in bone mi ...... ronic acid after hip fracture.
@en
prefLabel
Subgroup variations in bone mi ...... ronic acid after hip fracture.
@ast
Subgroup variations in bone mi ...... ronic acid after hip fracture.
@en
P2093
P2860
P356
P1476
Subgroup variations in bone mi ...... ronic acid after hip fracture.
@en
P2093
Carl F Pieper
Cathleen S Colón-Emeric
Chris Recknor
Christina Bucci-Rechtweg
Denise L Orwig
Jay S Magaziner
Jonathan D Adachi
Kenneth W Lyles
Lars Nordsletten
P2860
P304
P356
10.1002/JBMR.2283
P577
2014-12-01T00:00:00Z